sgen it could simply be a matter of risk benefit - the cascade trial is for older pts w limited options (certainly nothing curative). allo transplants have enormous mortality and morbidity associated but is meant to be curative i know it is holiday season but sgen really should hold a cc to clarify what they can
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.